3-acetylamino-2-bromo-6-nitro-benzoic acid methyl ester | 731810-13-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-acetylamino-2-bromo-6-nitro-benzoic acid methyl ester
• 英文别名: methyl 3-acetylamino-2-bromo-6-nitrobenzoate；Methyl 3-acetamido-2-bromo-6-nitrobenzoate
• CAS: 731810-13-2
• 化学式: C₁₀H₉BrN₂O₅
• 分子量: 317.096
• InChiKey: NDEJTWZBRHNXNB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  101
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  3-acetylamino-2-bromo-6-nitro-benzoic acid methyl ester 在 tris-(dibenzylideneacetone)dipalladium(0) 、 di-tert-butylneopentylphosphonium tetrafluoroborate potassium tert-butylate 作用下， 以 1,4-二氧六环 、 N-甲基吡咯烷酮 、 二甲基亚砜 为溶剂， 反应 1.5h， 生成 methyl 5-nitro-2-[3-(tetrahydropyran-2-yloxy)-propyl]-1H-indole-4-carboxylate
  参考文献：
  名称：

  [EN] TRICYCLIC SULFONAMIDE COMPOUNDS AND METHODS OF MAKING AND USING SAME
  [FR] COMPOSÉS DE SULFONAMIDE TRICYCLIQUES ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION

  摘要：

  这项发明提供了三环磺胺类化合物及其在治疗医学疾病（如肥胖症）中的应用。提供了制备各种三环化合物的药物组合物和方法。这些化合物被认为具有对甲硫氨酰氨基肽酶2的活性。

  公开号：

  WO2012154678A1

文献信息

• [EN] DIAZEPINOINDOLE DERIVATIVES AS KINASE INHIBITORS<br/>[FR] DERIVES DE DIAZEPINOINDOLE EN TANT QU'INHIBITEURS DE KINASE
  申请人：PFIZER

  公开号：WO2004063198A1

  公开（公告）日：2004-07-29

  Protein kinase, such as CHK-1, inhibiting tricyclic compounds of the following formula (wherein R2, R3 and R4 are as defined in the specification) pharmaceutical compositions containing effective amounts of said compounds or their salts are useful as a single agent or in combination with an anti-neoplastic agent or therapeutic radiation having an anti-neoplastic effect for treating diseases or conditions, such as cancers.

  蛋白激酶，如CHK-1，抑制以下式的三环化合物（其中R2、R3和R4如规范中定义）的药物组合物，含有所述化合物或其盐的有效量，可用作单一药剂或与抗肿瘤药剂或具有抗肿瘤效果的治疗放射剂结合，用于治疗疾病或病况，如癌症。
• TRICYCLIC COMPOUNDS PROTEIN KINASE INHIBITORS FOR ENHANCING THE EFFICACY OF ANTI-NEOPLASTIC AGENTS AND RADIATION THERAPY
  申请人：Benedict Suzanne

  公开号：US20070135415A1

  公开（公告）日：2007-06-14

  Protein kinase, such as CHK-1, inhibiting tricyclic compounds of the following formula (wherein R 2 , R 3 and R 4 are as defined in the specification) pharmaceutical compositions containing effective amounts of said compounds or their salts are useful as a single agent or in combination with an anti-neoplastic agent or therapeutic radiation having an anti-neoplastic effect for treating diseases or conditions such as cancers. The current invention relates to the making and using of such compounds.

  蛋白激酶，例如CHK-1，抑制以下式子中三环化合物（其中R2，R3和R4如规范所定义）的制剂（或其盐）的有效量的制药组合物，可用作单一剂量或与抗肿瘤剂或具有抗肿瘤作用的治疗性放射线组合使用，用于治疗癌症等疾病或病情。本发明涉及制备和使用这种化合物。
• Tricyclic Sulfonamide Compounds and Methods of Making and Using Same
  申请人：Cramp Susan Mary

  公开号：US20140073623A1

  公开（公告）日：2014-03-13

  The invention provides tricyclic sulfonamide compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making various tricyclic compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.

  该发明提供了三环磺酰胺化合物及其在治疗医学疾病，如肥胖症方面的用途。还提供了制备各种三环化合物的药物组合物和方法。考虑到这些化合物具有对甲硫氨酰基氨肽酶2的活性。
• TRICYCLIC SULFONAMIDE COMPOUNDS AND METHODS OF MAKING AND USING SAME
  申请人：Zafgen, Inc.

  公开号：US20160256469A1

  公开（公告）日：2016-09-08

  The invention provides tricyclic sulfonamide compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making various tricyclic compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.

  本发明提供了三环磺酰胺类化合物及其在治疗医学疾病，如肥胖症方面的应用。还提供了制备各种三环化合物的制药组合物和方法。这些化合物被认为具有对甲硫氨酰氨肽酶2的活性。
• Compositions comprising diazepinoindole derivatives as kinase inhibitors
  申请人：Pfizer, Inc.

  公开号：EP1947102A1

  公开（公告）日：2008-07-23

  The present invention relates to the combined use of a compound of formula (I) wherein A, X, Y, Z, R2, R3 and R4 are as defined in the description, and an anti-neoplastic agent, for the treatment of neoplasms.

  本发明涉及式（I）化合物的综合利用 其中 A、X、Y、Z、R2、R3 和 R4 如说明书中所定义、 和一种抗肿瘤剂，用于治疗肿瘤。